4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001405253-26-000007
See Remarks sold 6,430 shares at an average $68.36 ($439,566)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrow Jeffrey S See Remarks | 2026-03-17 | Sale | −2,111 | $69.42 | $146,546 | 47,635 | D |
| Farrow Jeffrey S See Remarks | 2026-03-18 | Sale | −2,133 | $68.71 | $146,558 | 45,502 | D |
| Farrow Jeffrey S See Remarks | 2026-03-19 | Sale | −2,186 | $67.00 | $146,462 | 43,316 | D |
| Open-market sales · 6,430 sh · avg $68.36 · $439,566 | |||||||
Loading xslF345X06/wk-form4_1773961430.xml…